Literature DB >> 2120404

Chlorins as photosensitizers in biology and medicine.

J D Spikes1.   

Abstract

The photodynamic therapy (PDT) of tumors involves illumination of the tumorous area following the administration of a tumor-localizing photodynamic sensitizer. Hematoporphyrin derivative (HPD) and Photofrin II (a purified form of HPD), the main sensitizers used clinically for PDT to date, are complex mixtures of porphyrins; furthermore, these preparations absorb light very poorly in the red region of the spectrum (wavelengths greater than 600 nm) where light penetration into mammalian tissues is greatest. Thus there is considerable interest in identifying new sensitizers that localize more effectively in tumors, absorb more strongly at longer wavelengths and can be prepared in high purity. Much of this interest has been directed towards chlorins (reduced porphyrins), which typically absorb strongly in the red. This review summarizes research that has been carried out on selected types of chlorins, some of which may have important applications as sensitizers for PDT.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120404     DOI: 10.1016/1011-1344(90)85096-f

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  22 in total

Review 1.  Plasmonic photothermal therapy (PPTT) using gold nanoparticles.

Authors:  Xiaohua Huang; Prashant K Jain; Ivan H El-Sayed; Mostafa A El-Sayed
Journal:  Lasers Med Sci       Date:  2007-08-03       Impact factor: 3.161

2.  Photophysics of glycosylated derivatives of a chlorin, isobacteriochlorin and bacteriochlorin for photodynamic theragnostics: discovery of a two-photon-absorbing photosensitizer.

Authors:  Amit Aggarwal; Sebastian Thompson; Sunaina Singh; Brandon Newton; Akeem Moore; Ruomie Gao; Xinbin Gu; Sushmita Mukherjee; Charles Michael Drain
Journal:  Photochem Photobiol       Date:  2013-11-28       Impact factor: 3.421

Review 3.  Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.

Authors:  F S De Rosa; M V Bentley
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

4.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

5.  Redox-sensitive cross-linking enhances albumin nanoparticle function as delivery system for photodynamic cancer therapy.

Authors:  Anna M Molina; Moraima Morales-Cruz; Marimar Benítez; Kiara Berríos; Cindy M Figueroa; Kai Griebenow
Journal:  J Nanomed Nanotechnol       Date:  2015-05-22

Review 6.  Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.

Authors:  Carlos Tassa; Stanley Y Shaw; Ralph Weissleder
Journal:  Acc Chem Res       Date:  2011-06-10       Impact factor: 22.384

7.  Detection and Treatment of Diseases Using Light.

Authors:  W Pham
Journal:  IFMBE Proc       Date:  2010-01-11

8.  Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH.

Authors:  Liyi Huang; Timur Zhiyentayev; Yi Xuan; Dulat Azhibek; Gitika B Kharkwal; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-04       Impact factor: 4.025

Review 9.  Photodynamic therapy with fullerenes.

Authors:  Pawel Mroz; George P Tegos; Hariprasad Gali; Tim Wharton; Tadeusz Sarna; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2007-10-08       Impact factor: 3.982

10.  Photosensitizer-gold nanorod composite for targeted multimodal therapy.

Authors:  Jian Wang; Mingxu You; Guizhi Zhu; Mohammed Ibrahim Shukoor; Zhuo Chen; Zilong Zhao; Meghan B Altman; Quan Yuan; Zhi Zhu; Yan Chen; Cheng Zhi Huang; Weihong Tan
Journal:  Small       Date:  2013-05-10       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.